328419
Impact of Dementia on Quality of Care in Nursing Homes
Data sources included Medicare beneficiary enrollment file, Medicare hospital claims, the Minimum Data Set, and data from LTCFocus.org. Study population included 1,104,637 long-term care residents from 14,178 NHs in 2007.
Urinary incontinence (UI), depressive/anxious symptoms (DA), and potentially avoidable hospitalizations (PAH) were the quality measures (QMs) examined. The key independent variable, facilities’ prevalence of dementia, was categorized into three groups: low (<37%); medium (37%-67%, reference); and high (>67%).
We fit logistic (QM=UI, DA) and Poisson (QM=PAH) regression models with facility random-effects. One third of residents deteriorated in UI in the first quarter; 14% became more depressed or anxious between two assessments; and 18% experienced at least one PAH within a year. In NHs with low prevalence of dementia, residents with dementia had a reduced risk of deterioration in UI (OR=0.88, 95%CI=0.82-0.94) and DA (OR=0.90, 95%CI=0.85-0.94), as did residents without dementia (UI: OR=0.95, 95%CI=0.90-1.00; DA: OR=0.89, 95%CI=0.85-0.93), compared to residents in NHs with medium dementia prevalence. In NHs with high prevalence of dementia, residents with dementia had a reduced risk of PAHs (IRR=0.97, 95%CI=0.94-1.00), while residents without dementia had an increased risk of deterioration in DA (OR=1.08, 95%CI=1.03-1.13).
NHs with high dementia prevalence appear to provide better quality of care to residents with dementia. However, facilities with few dementia residents seem to provide better quality to both populations. Future research should explore the benefits of operating special dementia care facilities.
Learning Areas:
Public health or related researchLearning Objectives:
Demonstrate whether and how facility-level dementia prevalence differentially impacts quality of care in nursing homes for residents with and without dementia.
Keyword(s): Dementia, Quality of Care
Qualified on the content I am responsible for because: This study was part of my PhD dissertation research. I conducted the study independently with the guidance of my dissertation committee members (co-authors).
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.